- Home
- INKT vs DRIO Comparison
INKT vs DRIO Comparison
Compare INKT & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INKT
- DRIO
- Stock Information
- Founded
- INKT 2017
- DRIO 2011
- Country
- INKT United States
- DRIO United States
- Employees
- INKT N/A
- DRIO N/A
- Industry
- INKT Medicinal Chemicals and Botanical Products
- DRIO Medical/Dental Instruments
- Sector
- INKT Health Care
- DRIO Health Care
- Exchange
- INKT Nasdaq
- DRIO Nasdaq
- Market Cap
- INKT 75.7M
- DRIO 30.5M
- IPO Year
- INKT 2021
- DRIO N/A
- Fundamental
- Price
- INKT $17.00
- DRIO $0.57
- Analyst Decision
- INKT Hold
- DRIO Strong Buy
- Analyst Count
- INKT 3
- DRIO 2
- Target Price
- INKT $37.50
- DRIO $2.50
- AVG Volume (30 Days)
- INKT 2.9M
- DRIO 142.8K
- Earning Date
- INKT 08-12-2025
- DRIO 08-07-2025
- Dividend Yield
- INKT N/A
- DRIO N/A
- EPS Growth
- INKT N/A
- DRIO N/A
- EPS
- INKT N/A
- DRIO N/A
- Revenue
- INKT N/A
- DRIO $28,034,000.00
- Revenue This Year
- INKT N/A
- DRIO $20.85
- Revenue Next Year
- INKT N/A
- DRIO $17.09
- P/E Ratio
- INKT N/A
- DRIO N/A
- Revenue Growth
- INKT N/A
- DRIO 47.20
- 52 Week Low
- INKT $4.56
- DRIO $0.50
- 52 Week High
- INKT $76.00
- DRIO $1.55
- Technical
- Relative Strength Index (RSI)
- INKT 49.44
- DRIO 22.87
- Support Level
- INKT $18.54
- DRIO $0.65
- Resistance Level
- INKT $20.25
- DRIO $0.74
- Average True Range (ATR)
- INKT 8.24
- DRIO 0.05
- MACD
- INKT -1.13
- DRIO -0.01
- Stochastic Oscillator
- INKT 13.41
- DRIO 11.36
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.